AN IN-VIVO STUDY TO EVALUATE THE ANTI-ULCER ACTIVITY OF NĀRIKELĀ LAVANA IN PYLORIC LIGATION INDUCED ULCER IN WISTAR ALBINO RATS
HTML Full TextAN IN-VIVO STUDY TO EVALUATE THE ANTI-ULCER ACTIVITY OF NĀRIKELĀ LAVANA IN PYLORIC LIGATION INDUCED ULCER IN WISTAR ALBINO RATS
Reshmi *, Abhaya Kumar Mishra, Sudhakar Bhat and Arun Mohanan
Department of Rasashastra and Bhaishajya Kalpana (Medicinal Chemistry and Pharmacy), Amrita School of Ayurveda, Amritapuri, Amrita Vishwa Vidyapeetham, Kollam, Kerala, India.
ABSTRACT: Lavana kalpanas are pharmaceutical preparation in which the ‘Lavana’ and the selected ‘auṣadhadravyā’ are igniting together in a closed sampuṭā to obtain the drug ash as medicinal product. Nārikelā lavana, one among the lavana kalpana mentioned in Bhaiṣajyaratnāvali 30th chapter and in Rasa taraṇgiṇi14th chapter. Nārikelā lavaṇa proved to have a high amount of electrolytes like calcium and potassium, which have antacid properties. Here the common ingredient in this Kalpana is lavana, which possesses madhura-lavanarasa & śītaviryā and having pittahara property which might be the reason for the extensive use of Lavaṇa Kalpanasin pittajanyavikaras. The higher alkalinity of Nārikelā lavaṇa may also play an important role in its mode of action. Materials and Methods: Nārikelā lavana was prepared as per the reference in Rasa taraṇgiṇi, and analytical parameters were tested. The experimental study was conducted in pyloric ligated Wistar albino rats. Then the data were analyzed statistically using One Way ANOVA followed by Dunnett’s multiple “t” test as a post hoc test. Results & Discussion: The analytical parameters like pH, LOD, Total ash, Acid insoluble ash, water-soluble ash etc. were tested, and the results were found to be within the permeable limits. The trial drug (Nārikelā lavana) shows significant results in total acidity, free acidity, and ulcer index by analyzing various parameters indicating the anti-ulcer activity. Conclusion: The obtained results clearly indicate Nārikelā lavana possesses anti-ulcer activity.
Keywords: Narikela lavana, Antiulcer study, In-vivo anti-ulcer study
INTRODUCTION: Peptic ulcer is the most predominant gastrointestinal disease; current therapy for Peptic ulcer is H2-receptor blockers, proton pump inhibitors, antacids, anticholinergics, and antibiotics.
Currently available treatments have limited efficacy and severe side effects. Hence, ulcer treatment is one of the challenging problems, and the researchers are looking forward to a drug with the minimal side effect, easily accessible & affordable.
Nārikelā lavaṇa, one among the Lavana kalpana mentioned in Bhaiṣajyaratnāvali 30th chapter and in Rasa taraṇgiṇi 14th chapter. Its main indication mentioned in both texts are śūla, especially in pariṇāmaśūla. By analyzing symptoms śūlac an be co-related to peptic ulcers.
Nārikelā lavana was proved to have a high amount of electrolytes like calcium and potassium, which has antacid properties. Here the common ingredient in this Kalpana is lavana, which possess madhura-lavanarasa & śītaviryā and having pittahara property which might be the reason for the extensive use of Lavaṇa kalpanas in Pittajanyavikaras. The higher alkalinity of Nārikelā lavaṇa may also play an important role in its mode of action.
Aims and Objectives: To analyze the pysico-chemical properties of Nārikelā lavaṇa and to experimentally evaluate the anti-ulcer activity of Nārikelā lavaṇa.
MATERIALS AND METHODS
Pharmaceutical Study: Pharmaceutically authentic and pure drugs were collected, and later Nārikelā lavaṇa was prepared according to the reference from Rasa taraṇgiṇi 1. Nārikelā lavaṇa consists of only 2 ingredients- nārikelā and Saindhavā lavaṇa. A mature coconut devoid of outer fibrous part is taken & a hole is made into one of its eyes, and all the liquid inside is poured out. Saindhavā lavaṇa should be powdered well and poured into the coconut through the hole. The hole is now plugged with a mud cork. A layer of multanimitti smeared cloth was covered on the coconut and allowed it to dry, and the process was repeated 3 times. After proper drying of layers, it was subjected to Mahaputa 2. The temperature was taken every 10 min using a thermocouple.
Analytical Study: Nārikelā lavaṇa was analyzed by doing the following tests: -Loss on Drying (LOD), Total ash, Acid insoluble ash, Water soluble ash, pH (5% solution) 3, 4.
Experimental Study: Wistar strain albino rats weighing between 160 to 250g of either sex were used for the study. The Institutional Animal Ethical Committee approved all experimental protocols following the guideline formulated by CPCSEA and Approval No. SDMCRA/IAEC/AM-R-01. In pyloric ligation-induced ulcers, an experimental study was conducted in 3 groups, i.e., control, standard and trial groups with 8 Wistar albino rats, which were randomly selected. A day before dosing, the selected animals would be randomly divided into three groups comprising 4 male and 4 female Wistar albino rats.
The test drugs would be administered for 7 consecutive days. Ranitidine was administered for 4 consecutive days prior to pyloric ligation for the reference standard group. The control group, CMC solution and distilled water were also given for 7 consecutive days. Animals would be fasted for 36-40 hours by placing them in metabolic cages to prevent coprophagy but provided free access to water ad libitum. The dosing would be continued during this period. On the tenth day, one hour after dosing, pylorus was ligated by the method of Shay et al. (1945) 5.
Pre Operative: Rats were anesthetized with Inj. Ketamine 80mg/kg body weight (Intraperitoneal) Fig. 1 and Inj. Xyloxine 3mg/kg body weight (Intra Muscular) Fig. 2 for analgesic action. Shaving of the ventral part of the abdomen of rats was done 6 Fig. 3.
FIG. 1: FIG. 1: KETAMINE INJECTION (IP)
FIG. 2: XYLOXINE INJECTION (IM)
FIG. 3: SHAVING OF VENTRAL PART
Operative Procedure: On the ventral part of the abdomen portion was opened in a layer by a small midline incision just below and lateral to the xiphoid process Fig. 4. Pyloric portion of the stomach was slightly lifted out, avoiding traction to the pylorus or damage to its blood supply. The pylorus was ligated with linen thread No.10 and stomach was replaced carefully Fig. 5. The incision was closed with interrupted sutures in layers & betadine ointment was applied over the sutures 7.
FIG. 4: ANESTHETIZED RAT ON DISSECTION TABLE
FIG. 5: PYLORIC LIGATION
Post Operative Procedure: Each rat was kept in an individual metabolic cage. The animals were deprived of both food and water. Animals were euthanized under deep ether anesthesia at the end of 10 h after pyloric ligation 8. The abdominal cavity was reopened carefully, and the stomach was excised after tying the esophageal end to prevent loss of gastric contents during excision Fig. 6. Gastric contents were drained into tubes and centrifuged at 2000 rpm for 10 min Fig. 7. The gastric juice's volume and pH were noted and used for biochemical estimation. The stomach was opened along the greater curvature and washed under the running tap water. Then it was fixed on a wax board & observed the ulcers using a magnifying lens Fig. 8. After assessing the ulcer score, the glandular portion of the stomach was sent for histopathological assessment 9, 10.
FIG. 6: PYLORIC LIGATED STOMACH
FIG. 7: COLLECTION OF GASTRIC JUICE
FIG. 8: ULCER ASSESSMENT
RESULTS: The data obtained were analyzed using Graph pad in stat version 3.05 by student “t” test for comparison between two positive control groups and the rest of the data were analyzed by One Way ANOVA followed by Dunnett’s multiple “t” test as a post hoc test for determining the level of significance of the observed effects. Eight parameters were analyzed during the study.
pH of Gastric Juice: The data in the Table 1 shows there was an increase in gastric pH in the standard group when compared to the control group, the observed increase was found to be statistically very significant and there was an increase in gastric pH in test group when compared to the control group, the observed increase was found to be statistically non-significant.
TABLE 1: EFFECT OF NĀRIKELĀ LAVANA ON PH OF GASTRIC JUICE
Group | pH | % change |
Control | 2.71±0.28 | |
Standard | 5.75±0.25** | 112.17↑ |
Test | 3.58±0.61 | 32.10↑ |
Data: MEAN±SEM, **p<0.01.
Volume of Gastric Juice: The data in the Table 2 shows there was a decrease in gastric juice volume in the standard group when compared to the control group, the observed decrease was found to be statistically non-significant and there was an increase in gastric juice volume in the trial group when compared to the control group, the observed increase was found to be statistically non-significant.
TABLE 2 EFFECT OF NĀRIKELĀ LAVANA ON VOLUME OF GASTRIC JUICE
Group | Volume | % change |
Control | 1.57±0.46 | |
Standard | 0.75±0.18 | 52.22↓ |
Test | 2.75±0.65 | 75.15↑ |
Data: MEAN±SEM.
Free Acidity: The data in the Table 3 shows there was a decrease in free acidity in the standard group when compared to the control group, the observed decrease was found to be statistically significant, and there was a decrease in free acidity in the test group when compared to the control group, the observed decrease was found to be statistically very significant.
TABLE 3 EFFECT OF NĀRIKELĀ LAVANA ON FREE ACIDITY
Group | Free acidity | % change |
Control | 2.86±0.19 | |
Standard | 1.9±0.00* | 33.56↓ |
Test | 1.26±0.10** | 55.94↓ |
Data: MEAN±SEM, *P<0.05, **P<0.01
Total Acidity: The data in the Table 4 shows there was an increase in total acidity in the standard group when compared to the control group, the observed increase was found to be statistically non-significant and there was a decrease in total acidity in the test group when compared to the control group, the observed decrease was found to be statistically significant.
TABLE 4 EFFECT OF NĀRIKELĀ LAVANA ON TOTAL ACIDITY
Group | Total acidity | % change |
Control | 5.42±0.31 | |
Standard | 6±0.00 | 10.70↑ |
Test | 4.32±0.27* | 20.29↓ |
Data: MEAN±SEM, *P<0.05.
Ulcer Index: The data in the Table 5 shows there was a decrease in ulcer index in the standard group, when compared to the control group, the observed decrease was found to be statistically very significant, and there was a decrease in ulcer index in the test group when compared to the control group, the observed decrease was found to be statistically very significant.
TABLE 5: EFFECT OF NĀRIKELĀ LAVANA ON ULCER INDEX
Group | Ulcer index | % change |
Control | 10.85±2.25 | |
Standard | 3±0.82** | 72.35↓ |
Test | 4±0.87** | 63.13↓ |
Data: MEAN±SEM, **P<0.01
Carbohydrate Estimation: The data in the Table 6 shows there was a decrease of total carbohydrates in standard group when compared to the control group, the observed decrease was found to be statistically very significant and there was decrease in total carbohydrate in test group when compared to the control group, the observed decrease was found to be statistically non-significant.
TABLE 6: EFFECT OF NĀRIKELĀ LAVANA ON CARBOHYDRATE ESTIMATION
Group | Total carbohydrate | % change |
Control | 1809.2±232.65 | |
Standard | 706.2±143.90 | 60.96↓ |
Test | 1193.2±169.08 | 34.04↓ |
Data: MEAN±SEM, **P<0.01
Protein Estimation: The data in the Table 7 shows there was a decrease in total protein in the standard group when compared to the control group, the observed decrease was found to be statistically non-significant, and there was decrease in total protein in test group when compared to the control group, the observed decrease was found to be statistically non-significant.
TABLE 7: EFFECT OF NĀRIKELĀ LAVANA ON PROTEIN ESTIMATION
Group | Total protein | % change |
Control | 15788±1956.0 | |
Standard | 10141.2±1460.2 | 564680↓ |
Test | 12720±2761.6 | 19.43↓ |
Data: MEAN±SEM
Peptic Activity: The data in the Table 8 shows there was increase of peptic activity in the standard group when compared to the control group, the observed increase was found to be statistically non-significant and there was a decrease in peptic activity in test group when compared to the control group, the observed decrease was found to be statistically non-significant.
TABLE 8: EFFECT OF NĀRIKELĀ LAVANA ON PEPTIC ACTIVITY
Group | Peptic activity | % change |
Control | 360±64.797 | |
Standard | 537.8±98.090 | 49.38↑ |
Test | 345.6±87.782 | 4↓ |
Data: MEAN±SEM
Histopathological Examination of Stomach Tissue: Histopathological examination of stomach tissues was done and the following results were obtained.
Control Group: Stomach tissue sections of normal control group rats showed normal cytoarchitecture. Fig. 9 & 10. The data in Tables 9, 10, and 11 show the results of histopathological examination of stomach tissue of the control group, standard group, and trial group, respectively.
TABLE 9: SHOWING THE RESULT OF HISTOPATHOLOGY OF THE CONTROL GROUP
Group and rat no | Mucosal layer | Sub-mucosal layer | Muscular layer | Remarks |
C1A3 | Small area ulcerated, extending from mucosa to submucosa. Inflammatory cells seen. Loss of glandular architecture seen | No changes | No changes | Ulceration and inflammation |
C2B2 | Small area shows damaged epithelium | Edematous and inflamed Fig. 11 | Inflammatory cells seen | Inflammation |
C2B3 | Small eroded area seen. Glandular architecture lost in some areas | Edema and inflammation | No changes | Erosion. Fig. 12 severe inflammation |
Standard Group
TABLE 10: SHOWING THE RESULTS OF HISTOPATHOLOGY OF STANDARD GROUP
Group and rat no | Mucosal layer | Sub-mucosal layer | Muscular layer | Remarks |
S1A1 | No necrosis or erosion, Glandular architecture maintained. Fig. 13, 14 | Inflammatory cells | No changes | Inflammation |
S1A4 | No necrosis or erosion, Glandular architecture maintained | Inflammatory cells | No changes | Inflammation |
S2A2 | No necrosis or erosion, Glandular architecture maintained | Inflammatory cells | No changes | Inflammation |
Trial Group
TABLE 11: SHOWING THE RESULTS OF HISTOPATHOLOGY OF THE TRIAL GROUP
Group and rat no | Mucosal layer | Sub-mucosal layer | Muscular layer | Remarks |
G1A1 | No necrosis or erosion, Fig. 15 Glandular architecture changed in one area. Inflammatory cells like eosinophils, lymphocytes seen. | Inflammatory cells | No changes | Inflammation |
G1A2 | Glandular architecture maintained. No necrosis or erosion | Inflammatory cells | Inflammatory cells | No ulcer, erosion, necrosis. Fig. 16 Inflammation |
G1A3 |
Glandular architecture maintained. No necrosis or erosion. Many Inflammatory cells like eosinophils, lymphocytes seen | Inflammatory cells | Inflammatory cells | No necrosis, ulcer, erosion. Inflammation seen |
Photomicrograph of Histopathology of Normal Stomach Tissue:
FIG. 9: NORMAL STOMACH TISSUE
FIG. 10: ABSENCE OF NECROSIS/EROSION
Photomicrograph of Histopathology of Control Group:
FIG. 11: ODEMA AND INFLAMMATION OF SUBMUCOSA
FIG. 12: MUCOSAL EROSION
Photomicrograph of Histopathology of Standard Group:
FIG. 13: ABSENCE OF ULCER
FIG. 14: MUCOSAL EROSION ABSENT
Photomicrograph of Histopathology of Trial Group:
FIG. 15: ULCERATED TISSUES NOT SEEN
FIG. 16: ABSENCE OF MUCOSAL EROSION
DISCUSSION: The outcome of the experimental study has been provided in the form of a consolidated table as follows for easy comparison and discussion. Data in Table 12 shows the SD in total acidity, free acidity & ulcer index, indicating the anti-ulcer activity. A decrease in the total acidity implies reduced HCl along with organic acids. A decrease in the free acidity implies reduced HCl secretion. A decrease in ulcer index implies prevention of ulcer formation. By Analysing the ayurvedic pharmacological properties of the formulation, the main ingredients - Nārikelā & Saindhavā lavaṇa possess Madhural avanarasa, śītavīrya, laghu-snigdhaguna, madhuravipāka and vātapittahara properties. Madhura and lavanarasa of the formulation will pacify the vitiated vāta. Madhura vipāka and śītavīrya of the formulation may increase the mucosal secretion and thereby preventing the ulceration. Madura rasa is Sandhanakrit, which also might help in healing the ulcer. Pharmacological studies on the drug, Nārikelā revealed the presence of alkaloids, tannins, resins, and phenolic compounds such as terpenoids, steroids etc 11.
Tannin and alkaloids were proved to be having anti-ulcer activity, which prevents ulceration 12. The presence of phenolic compounds acts as anti-oxidant, that reduces the formation of free radicals and thus potentially protects the cell from oxidative damage 13. An analytical study on the formulation revealed higher alkalinity of 9.64, shows the significant effect on preventing the ulceration. Ash value was found to be 90.84%, indicating the richness of minerals present in the sample, which inturn raises its therapeutic efficiency. Higher water-soluble ash (87.4%) and lower acid insoluble ash (1.24%) in turn indicating its higher solubility and the absence of impurities, respectively.
Low LOD value (1.04%) ensures a longer shelf life of the sample. In an in-vivo study, a significant decrease in total acidity, free acidity and ulcer index were found compared to the pyloric ligated control group. Phytochemicals like tannin, and alkaloids were proved to have anti-ulcer activity by reducing the acid secretion might be the reason behind this significant decrease. The presence of phenolic compounds acts as anti-oxidant, thus repairing the damaged cells, and higher alkalinity of the formulation also prevents the formation of an ulcer. In the histopathology of the test drug group, the ulceration was found to be minimal when compared to control group. While considering the overall factors related to the mechanism of healing ulcer, the main three things to be considered are acid neutralization, reducing the secretion and mucosal protection.
Saindhavā lavaṇa in the formulation helps in neutralization and reducing the acid secretion. Nārikelā, in the formulation proved to have anti-oxidant might help in mucosal protection. By considering these factors, we can claim that our formulation Nārikelā lavana act in preventive way than curative in ulceration.
TABLE 12: SHOWING THE RESULTS OF VARIOUS PARAMETERS TESTED IN GASTRIC JUICE OF WISTAR ALBINO RATS
Parameters | Standard | Trial |
pH | SI | NSI |
Volume of gastric juice | NSD | NSI |
Total acidity | NSI | SD |
Free acidity | SD | SD |
Ulcer index | SD | SD |
Carbohydrate estimation | SD | NSD |
Protein estimation | NSD | NSD |
Peptic activity | NSI | NSD |
Where, NSD- Non significant decrease; SD- significant decrease; NSI- Non significant increase; SI-Significant increase
CONCLUSION: The analytical parameters like pH, LOD, Total ash, Acid insoluble ash, Water soluble ash etc were tested and the results was found to be within the permeable limits. The trial drug (Nārikelā lavana) shows significant results in total acidity, free acidity, and ulcer index by analyzing various parameters indicating the anti-ulcer activity. Thus, the obtained results clearly indicate Nārikelā lavana possesses anti-ulcer activity.
ACKNOWLEDGEMENT: I would like to express my sincere gratitude towards Dr. Ramesh N.V (HOD, Dept. of RSBK), Dr. Dhanya, Dr. Vineeth P. K (Assistant professor, Dept. of RSBK), Bri. Shylaja (Quality control laboratory), Dr. Aansu susan Varghese, Dr. Devipriya. S, Dr. Lekshmi C. S, Dr. Sangeetha Nandakumar N. K, Dr. Veena. G-PG scholars, Amrita School of Ayurveda, for their valuable suggestions and support.
CONFLICTS OF INTEREST: We declare no conflicts of interest
REFERENCES:
- Sadanada Sharma: Rasa Tarangini, chaukhamba surbharati prakashan, Varanasi, Edition 2015; 11: 235-236.
- KR: Shrikantha Moorty: Sharangadhara Samhita, Choukambha Orientalia, Varanasi. 3rd Edition 1997; 242.
- of AYUSH, Ministry Of Health And Family Welfare,Govt. of India, the ayurvedic pharmacopoeia of India, The controller of Publications Civil Lines, Delhi, 1, 2010; 1(140): 141-191.
- Gaikwad A, More N and Wele A: pharmaceutical and analytical study of narikelalavana. International Journal of Ayurveda and Pharma Research 2015; 3(10): 2322–902.
- Alefe Norahun Mekonnen, Seyfe Asrade Atnafie, Mohammedbirhan A. Wahab Atta, "Evaluation of Anti-ulcer Activity of 80% Methanol Extract and Solvent Fractions of the Root of Croton macrostachyus Hocsht: Ex Del. (Euphorbiaceae) in Rodents. Evidence-Based Complementary and Alternative Medicine 2020; 11: 2020. Article ID 2809270.
- Sahoo SK, Sahoo HB, Priyadarshini D, Soundarya G, Kumar CK and Rani KU: Antiulcer Activity of Ethanolic Extract of Salvadora indica (W.) Leaves on Albino Rats. J Clin Diagn Res. 2016; 10(9): 07-10.
- Vijayakumar AR, Daniel EP, Ilavarasan R, Venkataraman S and Vijayakumar S: Ulcer Protective Activity of Jatropha gossypiifolia Linn. in Wistar Rats. Pharmacognosy Res. 2016; 8(1): 61-6. doi: 10.4103/0974-8490.178640. PMID: 27114695; PMCID: PMC4821110
- Manowar Hussain, Iswar Hazarika and Anju Das: Pylorus ligation induced gastric ulcer protection by sesamum indicum ethanolic seed extract. Research & Reviews: A Journal of Pharmaceutical Science 2015; 6(3): 42–49.
- Sisay Zewdu W and Jemere Aragaw T: Evaluation of the Anti-Ulcer Activity of Hydromethanolic Crude Extract and Solvent Fractions of the Root of Rumex nepalensis in Rats. J Exp Pharmacol 2020; 12: 325-337 https://doi.org/10.2147/JEP.S258586
- Divyapraba M, Chitra P and Rameshwari KS: Anti-ulcer activity of Psidium guajava on pylorus ligation induced gastric ulcer in albino rats. Int J Pharm Sci & Res 2021; 12(1): 443-49. doi: 10.13040/IJPSR.0975-8232.12(1).443-49.
- Lima EB, Sousa CN and Meneses LN: Cocos nucifera (L.) (Arecaceae): A phytochemical and pharmacological review. Braz J Med Biol Res 2015; 48(11): 953-964. doi:10.1590/1414-431X20154773
- de Jesus NZ, de Souza Falcão H and Gomes IF: Tannins, peptic ulcers and related mechanisms. Int J Mol Sci 2012; 13(3): 3203-3228. doi:10.3390/ijms13033203
- Nyayiru Kannaian UP, Edwin JB, Rajagopal V, Nannu Shankar S and Srinivasan B: Phytochemical composition and antioxidant activity of coconut cotyledon. Heliyon [Internet] 2020; 6(2): 03411. Availablefrom: https://doi.org/10.1016/j.heliyon.2020.e03411.
How to cite this article:
Reshmi S, Mishra AK, Bhat S and Mohanan A: An in-vivo study to evaluate the antiulcer activity of Nārikelā lavana in pyloric ligation induced ulcer in Wistar albino rats. Int J Pharm Sci & Res 2022; 13(9): 3715-22. doi: 10.13040/IJPSR.0975-8232.13(9). 3715-22.
All © 2022 are reserved by International Journal of Pharmaceutical Sciences and Research. This Journal licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.
Article Information
37
3715-3722
1215 KB
318
English
IJPSR
S. Reshmi *, Abhaya Kumar Mishra, Sudhakar Bhat and Arun Mohanan
Department of Rasashastra and Bhaishajya Kalpana (Medicinal Chemistry and Pharmacy), Amrita School of Ayurveda, Amritapuri, Amrita Vishwa Vidyapeetham, Kollam, Kerala, India.
rashmivishnu2016@gmail.com
07 February 2022
11 March 2022
27 April 2022
10.13040/IJPSR.0975-8232.13(9).3715-22
01 September 2022